Jan 1, 1979

Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension

European Journal of Clinical Pharmacology
J Tuomilehto, A Nissinen

Abstract

A double-blind comparison of the beta-blockers metoprolol, alprenolol and oxprenolol was carried out to evaluate their antihypertensive effect and tolerability. 105 patients with previously untreated hypertension entered the trial and 72 completed it. Side-effects were infrequent and were never the reason for drop-out. All three drugs caused a statistically significant reduction in blood-pressure at the lower of the two doses used during a dose-finding period. At the higher dose employed in this period, metoprolol caused a significantly greater reduction in diastolic blood-pressure than did alprenolol or oxprenolol. All three drugs caused a significant reduction in heart rate. During the following period, the beta-blockers were supplemented if necessary with hydrochlorothiazide. This was required less frequently in the metoprolol group than in the other two groups.

Mentioned in this Paper

Diastolic Blood Pressure
Betalok
Propanolamines
Oxprenolol
Metoprolol
Hypertensive Disease
Antihypertensive Agents
In Blood
Clinical Trials
Hydrochlorothiazide

About this Paper

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.